Digitalis lanata in the order Lamiales. The original family name was Veronicaceae until 1789 when the family name became Plantaginaceae. This is the conserved name under the International Code of Botanical Nomenclature (ICBN). ICBN does not consider family names before 1789 for conservation, as a result Veronicaceae is not eligible for conservation. "Digitalis lanata" has several other common names such as "Grecian foxglove" and "woolly foxglove". The name Digitalis comes from the Latin word "digitus," which means finger. Digitalis was first recorded in the English language in 1664 in a published work. This genus name was chosen because the German name for
New Drug Application Review should complete within 6 months. The decision comes in a "Complete Response Letter". Biologics, such as vaccines and many recombinant proteins used in medical treatments are generally approved by FDA via a Biologic License Application (BLA), rather than an NDA. The manufacture of biologics is considered to differ fundamentally from that of less complex chemicals, requiring a somewhat different approval process. Generic drugs that have already been approved via an NDA submitted by another maker are approved via an Abbreviated New Drug Application (ANDA), which does not require all of the clinical trials normally required for a new drug